We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Cardinal Health Inc | NYSE:CAH | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.34 | 0.33% | 103.25 | 103.34 | 102.375 | 102.91 | 2,456,083 | 01:00:00 |
From May 2019 to May 2024
By Kimberly Chin
Cardinal Health Inc. (CAH) posted Thursday a more than fivefold surge in first-quarter profit, led by growth in its pharmaceuticals business despite generic drug competition pressures.
The Dublin, Ohio, company said profit was $593 million, or $1.94 a share, up from $115 million, or 36 cents a share, from a year earlier. Analysts were expecting the company to earn 69 cents a share, according to a Refinitiv poll.
On an adjusted basis, the company made $1.29 a share. Analysts expected $1.08 a share.
Sales increased 8% to $35.2 billion from the year prior, above the $33.65 billion estimated from analysts polled by Refinitiv. Sales from its pharmaceuticals segment rose 9%, while sales in its medical segment increased 2%.
The company reaffirmed its expectations of adjusted earnings of $4.90 to $5.15 a share for the year.
Write to Kimberly Chin at kimberly.chin@wsj.com
(END) Dow Jones Newswires
November 08, 2018 07:59 ET (12:59 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Cardinal Health Chart |
1 Month Cardinal Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
